The Setup

Between February and April 2025, three INFQ insiders made open-market stock purchases totaling over $1M at prices ranging from $8.20 to $11.40 per share. This is not a note about insider purchases in general — those are often noise. This is about these specific purchases, made by these specific people, at these specific prices.

What the Form 4s Actually Show

The SEC Form 4 filings tell a more specific story than the headlines. The purchases came from:

- Scott Faris (CEO): 45,000 shares purchased at $9.80–$11.20 average cost. These are open-market purchases — not RSU vesting, not options exercises.

- Ganesh Moorthy (Director, Microchip Technology CEO): 20,000 shares at $8.20. Moorthy's ownership stake is now material.

- Eric Bjornholt (Director, Microchip Technology CFO): 15,000 shares at $10.40.

The Microchip Technology purchases matter for a separate thesis (covered in the Bjornholt Signal piece). But the CEO purchases are the signal here.

Why Open-Market Purchases Signal Differently

Insiders receive equity compensation constantly. Vesting events, option exercises, and RSU releases all show up on Form 4s and mean nothing about outlook. Open-market purchases are different: the insider had to write a personal check from their own after-tax dollars.

At $9.80 average, Scott Faris paid over $440,000 of personal capital for stock he could receive in options for free. That's a specific signal about conviction in the near-term — insiders tend not to buy ahead of bad news.

The Share Class Structure Complication

INFQ's capital structure post-SPAC merger has two important features that affect how to read the insider purchases:

1. Lock-up shares: The 152M lock-up shares can't be sold until August 2026 (or the early release trigger). But Faris's purchased shares are not lock-up shares — they're freely tradeable. He could sell them tomorrow. He hasn't.

2. Conversion of private company equity: Pre-merger Infleqtion employees received shares at implied prices far below current market. The question is whether insiders buying at $10+ are simply dollar-cost-averaging into an already-low cost basis. For Faris, the answer appears to be no — his public company compensation equity vests on a 4-year schedule with a 1-year cliff, meaning his post-merger cost basis for vested shares is roughly in-line with or above market.

The Conviction Gap

Markets are pricing INFQ as a speculative quantum company with no path to profitability. The insider purchasing suggests management believes the valuation gap to fundamental value is material and near-term, not a 5-year story. That disconnect — between management's revealed preference and market pricing — is the investment thesis.

Note: Author holds a long position in INFQ. This is not investment advice.